HeartBeam (BEAT) Interest Expenses (2020 - 2021)
HeartBeam (BEAT) reported Interest Expenses of $744000.0 for Q4 2021, up 962.86% year-over-year from $70000.0 in Q4 2020, and little changed on a QoQ basis from $742000.0 in Q3 2021.
HeartBeam (BEAT) has 2 years of Interest Expenses data on file, last reported at $744000.0 in Q4 2021.
- Quarterly Interest Expenses rose 962.86% year-over-year to $744000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $744000.0 (down 8.37% YoY) and the FY2021 annual result came in at $2.2 million, up 673.21% from the prior year.
- Interest Expenses held at $744000.0 in Q4 2021 per BEAT's latest filing, from $742000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $744000.0 in Q4 2021 and bottomed at $63000.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 38.62 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 12.59 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 20.65 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | HeartBeam | 5.16 Mn | 5.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 744,000.00 |
| Dec 31, 2021 | 744,000.00 |
| Sep 30, 2021 | 742,000.00 |
| Sep 30, 2021 | 742,000.00 |
| Dec 31, 2020 | 70,000.00 |
| Dec 31, 2020 | 70,000.00 |
| Sep 30, 2020 | 63,000.00 |
| Sep 30, 2020 | 63,000.00 |